GLP-1 medicines may cut clot-related risks in chronically inflamed patients

GLP-1 medicines may cut clot-related risks in chronically inflamed patients

A large real-world analysis suggests GLP-1 receptor agonists may offer clot-related and survival benefits in a chronically inflamed, high-risk population, while... Read More
ADS

Subscribe To Newsletter

Get The Information First

DISCLOSURE: We may earn a commission when you use one of our coupons/links to make a purchase.